Literature DB >> 17028480

Incremental risk-factor reduction improves overall cardiovascular benefit: is it time to abandon the silos?

Jan Basile, Mark Houston, Carlos Ferrario.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17028480      PMCID： PMC8109554          DOI： 10.1111/j.1524-6175.2006.05158.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  22 in total

1.  AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association.

Authors:  S C Smith; P Greenland; S M Grundy
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

2.  Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests.

Authors:  P Greenland; S C Smith; S M Grundy
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

3.  Preventive Cardiology: How can we do Better? Proceedings of the 33rd Bethesda Conference. Bethesda, Maryland, USA. December 18, 2001.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2002-08-21       Impact factor: 24.094

4.  Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States.

Authors:  Michael E Minshall; Stéphane Roze; Andrew J Palmer; William J Valentine; Volker Foos; Joshua Ray; Claudia Graham
Journal:  Clin Ther       Date:  2005-06       Impact factor: 3.393

Review 5.  Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.

Authors:  K Kuulasmaa; H Tunstall-Pedoe; A Dobson; S Fortmann; S Sans; H Tolonen; A Evans; M Ferrario; J Tuomilehto
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

6.  Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).

Authors:  Charles D Meyers; Madeline McCarren; Nathan D Wong; Carlos Abraira; William C Duckworth; Moti L Kashyap
Journal:  Am J Cardiol       Date:  2006-05-04       Impact factor: 2.778

7.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

8.  Contemporary management of dyslipidemia in high-risk patients: targets still not met.

Authors:  Andrew T Yan; Raymond T Yan; Mary Tan; Daniel G Hackam; Kori L Leblanc; Heather Kertland; Jennifer L Tsang; Shahin Jaffer; Martin L Kates; Lawrence A Leiter; David H Fitchett; Anatoly Langer; Shaun G Goodman
Journal:  Am J Med       Date:  2006-08       Impact factor: 4.965

Review 9.  Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.

Authors:  Mark C Houston; Jan Basile; William H Bestermann; Brent Egan; Daniel Lackland; Ralph G Hawkins; Michael A Moore; James Reed; Philip Rogers; Daniel Wise; Carlos M Ferrario
Journal:  Am J Med Sci       Date:  2005-06       Impact factor: 2.378

10.  Prevalence of conventional risk factors in patients with coronary heart disease.

Authors:  Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272
View more
  5 in total

Review 1.  Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.

Authors:  Bernard Waeber; François Feihl; Luis M Ruilope
Journal:  Drugs       Date:  2009       Impact factor: 9.546

2.  Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative.

Authors:  JaNae Joyner; Michael A Moore; Debra R Simmons; Brian Forrest; Kristina Yu-Isenberg; Ron Piccione; Kirt Caton; Daniel T Lackland; Carlos M Ferrario
Journal:  J Contin Educ Health Prof       Date:  2014       Impact factor: 1.355

3.  The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.

Authors:  Carlos M Ferrario; Janae Joyner; Chris Colby; Alex Exuzides; Michael Moore; Debra Simmons; William Bestermann; Feride Frech-Tamas
Journal:  Vasc Health Risk Manag       Date:  2013-07-22

Review 4.  Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.

Authors:  Jasmina Varagic; Henry Punzi; Carlos M Ferrario
Journal:  Integr Blood Press Control       Date:  2014-11-26

Review 5.  The importance of prompt blood pressure control.

Authors:  Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.